ZA200503026B - Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer - Google Patents
Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancerInfo
- Publication number
- ZA200503026B ZA200503026B ZA200503025A ZA200503026A ZA200503026B ZA 200503026 B ZA200503026 B ZA 200503026B ZA 200503025 A ZA200503025 A ZA 200503025A ZA 200503026 A ZA200503026 A ZA 200503026A ZA 200503026 B ZA200503026 B ZA 200503026B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treating
- methods
- preventing cancer
- benzopyranone compounds
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical class C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41846902P | 2002-10-15 | 2002-10-15 | |
| US10/685,722 US7091235B2 (en) | 2002-10-15 | 2003-10-14 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200503026B true ZA200503026B (en) | 2006-11-29 |
Family
ID=32110155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200503025A ZA200503026B (en) | 2002-10-15 | 2003-10-15 | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US7091235B2 (enExample) |
| EP (1) | EP1556374A4 (enExample) |
| JP (1) | JP2006515275A (enExample) |
| KR (1) | KR20050072764A (enExample) |
| CN (1) | CN100457751C (enExample) |
| AU (1) | AU2003286441A1 (enExample) |
| BR (1) | BR0315400A (enExample) |
| CA (1) | CA2502064A1 (enExample) |
| IL (1) | IL168059A0 (enExample) |
| MX (1) | MXPA05003909A (enExample) |
| NZ (1) | NZ539675A (enExample) |
| WO (1) | WO2004035002A2 (enExample) |
| ZA (1) | ZA200503026B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| US7514438B2 (en) * | 2003-08-13 | 2009-04-07 | Amgen, Inc. | Melanin concentrating hormone receptor antagonist |
| CA2534428A1 (en) * | 2003-08-13 | 2005-03-03 | Paul A. Tempest | Melanin concentrating hormone receptor antagonists |
| AU2004274445A1 (en) * | 2003-09-15 | 2005-03-31 | Novartis Ag | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| CA2595472A1 (en) | 2005-01-21 | 2006-07-27 | Janssen Pharmaceutica N.V. | Novel coumarin derivatives as ion channel openers |
| JP2008543944A (ja) * | 2005-06-24 | 2008-12-04 | シグナル ファーマシューティカルズ，エルエルシー | 癌を治療するためのベンゾピラノン化合物 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US633155A (en) | 1898-02-23 | 1899-09-19 | William W Ramsay | Fence-repairing tool. |
| US5633155A (en) * | 1992-08-19 | 1997-05-27 | Jinro Limited | Expression vector for phytolacca antiviral protein and process for preparing transgenic plant transformed therewith |
| US6444688B1 (en) * | 1995-06-07 | 2002-09-03 | Eli Lilly And Company | Compounds and compositions with nitrogen-containing non-basic side chains |
| US6291456B1 (en) | 1998-12-30 | 2001-09-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| JP2002533456A (ja) | 1998-12-30 | 2002-10-08 | シグナル ファーマシューティカルズ， インコーポレイテッド | エストロゲン受容体のモジュレートを行うための化合物および方法 |
| US6331562B1 (en) | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| EP1246814B1 (en) | 1999-12-30 | 2005-02-16 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
| US7148252B2 (en) | 2001-10-03 | 2006-12-12 | Signal Pharmaceuticals, Llc | Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis |
| AU2003239155B2 (en) * | 2002-04-19 | 2008-12-04 | Novartis Ag | Benzopyranone compounds, compositions thereof, and methods of treatment therewith |
| US6620838B1 (en) * | 2002-04-19 | 2003-09-16 | Signal Pharmaceuticals, Inc. | Benzopyrazone compounds, compositions thereof, and methods of treatment therewith |
| US7091235B2 (en) * | 2002-10-15 | 2006-08-15 | Signal Pharmaceuticals, Llc | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
-
2003
- 2003-10-14 US US10/685,722 patent/US7091235B2/en not_active Expired - Fee Related
- 2003-10-15 BR BR0315400-9A patent/BR0315400A/pt not_active IP Right Cessation
- 2003-10-15 MX MXPA05003909A patent/MXPA05003909A/es active IP Right Grant
- 2003-10-15 KR KR1020057006631A patent/KR20050072764A/ko not_active Ceased
- 2003-10-15 JP JP2004545432A patent/JP2006515275A/ja active Pending
- 2003-10-15 CN CNB2003801043358A patent/CN100457751C/zh not_active Expired - Fee Related
- 2003-10-15 ZA ZA200503025A patent/ZA200503026B/xx unknown
- 2003-10-15 CA CA002502064A patent/CA2502064A1/en not_active Abandoned
- 2003-10-15 WO PCT/US2003/032932 patent/WO2004035002A2/en not_active Ceased
- 2003-10-15 EP EP03777639A patent/EP1556374A4/en not_active Withdrawn
- 2003-10-15 NZ NZ539675A patent/NZ539675A/en unknown
- 2003-10-15 AU AU2003286441A patent/AU2003286441A1/en not_active Abandoned
-
2005
- 2005-04-14 IL IL168059A patent/IL168059A0/en unknown
-
2006
- 2006-05-09 US US11/431,056 patent/US7358274B2/en not_active Expired - Fee Related
-
2008
- 2008-02-22 US US12/072,011 patent/US7589119B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20040225005A1 (en) | 2004-11-11 |
| WO2004035002A2 (en) | 2004-04-29 |
| WO2004035002A3 (en) | 2004-08-26 |
| EP1556374A4 (en) | 2007-12-19 |
| CA2502064A1 (en) | 2004-04-29 |
| CN1717405A (zh) | 2006-01-04 |
| CN100457751C (zh) | 2009-02-04 |
| US7091235B2 (en) | 2006-08-15 |
| NZ539675A (en) | 2006-10-27 |
| JP2006515275A (ja) | 2006-05-25 |
| BR0315400A (pt) | 2005-08-16 |
| EP1556374A2 (en) | 2005-07-27 |
| US20080146648A1 (en) | 2008-06-19 |
| IL168059A0 (en) | 2009-02-11 |
| US7589119B2 (en) | 2009-09-15 |
| US20060194866A1 (en) | 2006-08-31 |
| MXPA05003909A (es) | 2005-09-30 |
| US7358274B2 (en) | 2008-04-15 |
| AU2003286441A1 (en) | 2004-05-04 |
| KR20050072764A (ko) | 2005-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200503967B (en) | Agent for preventing or treating neuropathy | |
| EP2671581B8 (en) | Compositions and methods for treating cancer | |
| AU2003230750A1 (en) | Compositions and methods for treating cancer | |
| EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| PL371192A1 (en) | Polymer derivatives for treating metals | |
| IL164352A0 (en) | Methods for treating tweak-related conditions | |
| EP1572118A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CANCER WITH 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
| EP1476067A4 (en) | COMPOSITIONS AND METHODS FOR CANCER | |
| EP1551388A4 (en) | COMPOUNDS USEFUL IN THE TREATMENT OF CANCER, COMPOSITIONS AND METHODS COMPRISING THE SAME | |
| EP1509539A4 (en) | COMPOSITIONS AND METHODS RELATING TO CANCER | |
| EP1469769A4 (en) | NEW COMPOSITIONS AND METHODS AGAINST CANCER | |
| AU2002308642A1 (en) | Methods for treating cancer | |
| AP2004003070A0 (en) | The method of treating cancer. | |
| AU2003259202A8 (en) | Compositions and methods for treating and preventing infection | |
| ZA200503026B (en) | Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer | |
| AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
| AU2003258176A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| EP1469870A4 (en) | NEW COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | |
| AU2003224486A1 (en) | Composition for treating cancer containing n,n-dimethylphytosphingosine | |
| EP1599214A4 (en) | METHODS AND COMPOSITIONS FOR TREATING UTERINE COLON CANCER | |
| GB0223325D0 (en) | Treating cancer | |
| AU2002360454A8 (en) | Methods and compositions for treating cancer | |
| AU2003295604A8 (en) | Gpc15: methods and compositions for treating cancer | |
| AU2002342188A8 (en) | Methods and compositions for treating flavivirus-mediated disease | |
| AU2003258177A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |